ЧÀÍÈÈÏß
×ðÖØ¿Æѧ ¾´Î·ÖÆ¶È ×·ÇóЧÂÊ ¹Ø°®ÉúÃü
ѧÊõ¶¯Ì¬
¡¾HDSÊÖÒÕ×îÐÂÏ£Íû¡¿¡¶Frontiers in Oncology¡·±¨µ¼Ò¼ºÅÓéÀÖHDS¾«×¼ÓÃÒ©µä·¶°¸Àý2Àý
Ðû²¼Ê±¼ä£º
2021-09-01
½üÆÚ£¬£¬£¬£¬£¬£¬£¬ÖйúÒ½¿Æ´óѧÁ¥ÊôµÚһҽԺѪҺÄÚ¿ÆÔÚ Frontiers in Oncology ÆÚ¿¯Éϱ¨µ¼ÁË2ÀýÌØÊⲡÀý£ºÒ»ÀýÓÐÊýµÄ³ÉÈËB-ALLºÏ²¢TCF3-ZNF384»ùÒòÖØÅŲ¡Àý£¬£¬£¬£¬£¬£¬£¬ºÍÒ»Àý°éSET-CAN/NUP214ÈںϵĶùͯT-ALL²¡Àý¡£¡£¡£¡£¡£
2¸ö²¡Àýͨ¹ýHDSÌåÍâÒ©Ãô¼ì²âÊÖÒÕ̽Ë÷¸öÌ廯ÖÎÁÆÈ¡µÃÁËÍêÈ«»º½â£¬£¬£¬£¬£¬£¬£¬¸øÓÐÊýÈںϻùÒòÅä¾°µÄALLÖÎÁÆÌṩÁËеÄ˼Ð÷ºÍģʽ£¬£¬£¬£¬£¬£¬£¬ÒýÆðÁËÆÕ±é¹Ø×¢¡£¡£¡£¡£¡£
°¸ÀýÒ»£º³ÉÈËB-ALLºÏ²¢TCF3-ZNF384ÓÐÊý»ùÒòÖØÅÅ
»¼Õߣº41Ë꣬£¬£¬£¬£¬£¬£¬ÄÐÐÔ£¬£¬£¬£¬£¬£¬£¬2020Äê11ÔÂÈ·ÕïΪB-ALL£¬£¬£¬£¬£¬£¬£¬ºÏ²¢TCF3-ZNF384ÓÐÊý»ùÒòÖØÅÅ£¬£¬£¬£¬£¬£¬£¬»¼ÕßÔÚÒ»¸öÀο¿»¯ÁÆÖÜÆÚºó¸´·¢¡£¡£¡£¡£¡£
ͼƬȪԴ£ºFrontiers in Oncology July 2021 | Volume 11
ÒªÁ죺ȡÆä¹ÇËèÑù±¾¾ÙÐÐÌåÍâ°×Ѫ²¡Ï¸°û×÷Óý£¬£¬£¬£¬£¬£¬£¬¶Ô156ÖÖϸ°û¶¾ÐÔÒ©Îï¡¢°ÐÏòÖÎÁÆÒ©Îï¡¢ÁªºÏ»¯ÁÆÒ©ÎïµÈ¾ÙÐÐÃô¸ÐÐÔɸѡ£¬£¬£¬£¬£¬£¬£¬ÒÔÆÚÑ°ÕÒ¿ÉÄܵÄÖÎÁƼƻ®¡£¡£¡£¡£¡£
Ч¹û£º¼ì²â·¢Ã÷»¼Õ߸´·¢°×Ѫ²¡Ï¸°û¶Ô¼±ÐÔËèϸ°û°×Ѫ²¡£¡£¡£¡£¡£¨AML£©ºÍ¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡£¡£¡£¡£¡£¨ALL£©µÄÁªºÏ»¯ÁƼƻ®¼°¶àÖÖ°ÐÏòÒ©Îï¾ùÏÔʾÖжÈÃô¸Ð¡£¡£¡£¡£¡£ÆäÖУ¬£¬£¬£¬£¬£¬£¬hyper-CVAD£¨B£©¼Æ»®ÏÔʾ³öÓë¶à¸ö°ÐÏò»¯ºÏÎïµÄÐͬЧӦ£¬£¬£¬£¬£¬£¬£¬²¢ÇÒ¾ßÓнϸߵÄÖ×Áöϸ°ûɱÉËÒÖÖÆÂÊ¡£¡£¡£¡£¡£»£»£»£»¼ÕßÑ¡Ôñ¸ßCVAD£¨B£©¼Æ»®ÓëË÷À·ÇÄáÁªºÏ£¬£¬£¬£¬£¬£¬£¬»ñµÃÍêÈ«»º½â£¨CR£©£¬£¬£¬£¬£¬£¬£¬È»ºóÓëËèϵ¶¨Ïò¸ßÈý¼âɼõ¥¼î+°¢ÌÇ°ûÜÕ+ÈáºìùËØ£¨HAD£©¼Æ»®ºÏ²¢£¬£¬£¬£¬£¬£¬£¬»ñµÃ·Ö×ÓCR¡£¡£¡£¡£¡£
ר¼ÒµãÆÀ
ÎÞÂÛÃâÒß±íÐÍÔõÑù£¬£¬£¬£¬£¬£¬£¬TCF3-ZNF384°×Ѫ²¡¿ÉÄÜÊÇÒ»ÖÖÆæÒìµÄ°×Ѫ²¡ÑÇÐÍ¡£¡£¡£¡£¡£¿£¿£Ë¼Á¿µ½ÆµÈÔµÄÆ×ϵת»»ÒÔ¼°¶ÔALLºÍAMLµ¼Ïò¼Æ»®µÄÃô¸ÐÐÔ£¬£¬£¬£¬£¬£¬£¬½ÓÄÉÁÜϵ¡¢ËèϵºÍÔìѪ¸Éϸ°ûµÄÕûºÏÕ½ÂÔÓпÉÄÜΪTCF3-ZNF384ÐͳÉÈË°×Ѫ²¡ÕÒµ½³ö·£¬£¬£¬£¬£¬£¬£¬Ð¡·Ö×Ó°ÐÏòÒ©ÎïÌåÏÖ³öÒ»¶¨µÄDZÔÚ¼ÛÖµ£¬£¬£¬£¬£¬£¬£¬ÖµµÃ½øÒ»²½Ì½ÌÖÑо¿¡£¡£¡£¡£¡£
°¸Àý¶þ£º°éSET-CAN/NUP214ÈںϵĶùͯT-ALL
»¼Õߣº15Ë꣬£¬£¬£¬£¬£¬£¬Å®º¢£¬£¬£¬£¬£¬£¬£¬2019Äê10ÔÂÈ·ÕïΪT-ALL£¬£¬£¬£¬£¬£¬£¬°éÓÐSET-CAN/NUP214Èںϣ¬£¬£¬£¬£¬£¬£¬¶ÔͨÀýVICLP»¯ÁÆÌåÏÖ³öÔçÆÚÄÍÒ©ÐÔ£¨µÚ15Ì죬£¬£¬£¬£¬£¬£¬79.2%µÄBLAST£©£¬£¬£¬£¬£¬£¬£¬Ö»¹ÜÔÚµÚ28ÌìÓÕµ¼»¯Áƺó£¨18.85%µÄBLAST£©£¬£¬£¬£¬£¬£¬£¬°×Ѫ²¡¼ç¸ºÏÔÖø¼õÇᣬ£¬£¬£¬£¬£¬£¬µ«ÔÚµÚ¶þ¸öÁƳÌʹÓôó¼ÁÁ¿¼×°±µûßʺ;ÛÒÒ¶þ´¼ÌìÃŶ¬°±ËáºóÈÔδµÖ´ïÍêÈ«»º½â¡£¡£¡£¡£¡£
ͼƬȪԴ£ºFrontiers in Oncology March 2021 | Volume 11
ÒªÁ죺ȡÆä¹ÇËèÑù±¾¾ÙÐÐÌåÍâ°×Ѫ²¡Ï¸°û×÷Óý£¬£¬£¬£¬£¬£¬£¬¶Ô165ÖÖϸ°û¶¾ÐÔÒ©Îï¡¢°ÐÏòÖÎÁÆÒ©Îï¡¢ÁªºÏ»¯ÁÆÒ©ÎïµÈ¾ÙÐÐÌåÍâÒ©ÎïÃô¸ÐÐÔɸѡ¡£¡£¡£¡£¡£
Ч¹û£ºÁîÈ˾ªÑȵÄÊÇ£¬£¬£¬£¬£¬£¬£¬AMLÑù¼Æ»®DAE¼Æ»®£¨ÈáºìùËØ+°¢ÌÇ°ûÜÕ+×ãÒ¶ÒÒß°£©ºÍ¿¨·Ç×ôÃ×µÄÌåÍâÒÖÖÆÂÊ×î¸ß¡£¡£¡£¡£¡£»£»£»£»¼Õß½ÓÊÜDAE¼Æ»®»¯ÁÆ£¬£¬£¬£¬£¬£¬£¬×îÖÕÍêÈ«»º½â²¢½ÓÊÜÒì»ùÒòÔìѪ¸Éϸ°ûÒÆÖ²£¨allo-HSCT£©¡£¡£¡£¡£¡£
ר¼ÒµãÆÀ
SET-CAN/NUP214ÈںϵÄT-ALL»¼Õßͨ³£¶Ô»¯ÁÆÌåÏÖ³öÔçÆÚÄÍÒ©ÐÔ£¬£¬£¬£¬£¬£¬£¬µ«ËûÃÇÓÐÑÓ³Ù·´Ó¦£¬£¬£¬£¬£¬£¬£¬²¢ÇÒCRÂÊûÓнµµÍ£¬£¬£¬£¬£¬£¬£¬Òò´Ë£¬£¬£¬£¬£¬£¬£¬½¨ÒéÓÕµ¼ÖÎÁƽÓÄÉ28ÌìÁƳ̵Ļ¯ÁƼƻ®£¬£¬£¬£¬£¬£¬£¬ÈçGRAALL 2003Äê»ò2005ÄêʹÓõĻ¯ÁƼƻ®¡£¡£¡£¡£¡£
¶ÔÄÑÖÎÐÍT-ALL»¼¶ù£¬£¬£¬£¬£¬£¬£¬AMLÑùÖÎÁÆÈçDAE»òCLAGÁªºÏÌ춬õ£°·Ã¸¿ÉÄÜÊÇÓÐÒæµÄ¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬£¬¿¨·Ç×ôÃ׿ÉÄÜÊÇÒ»ÖÖÓÐÓõÄÖÎÁÆÒ©Î£¬£¬£¬£¬£¬£¬ÖµµÃ½øÒ»²½Ñо¿¡£¡£¡£¡£¡£ÎÒÃÇÏàÐÅ£¬£¬£¬£¬£¬£¬£¬Í¨¹ýÒ©ÃôÊÖÒÕµÄÖ¸µ¼¾ÙÐÐÊʵ±µÄÖÎÁÆ£¬£¬£¬£¬£¬£¬£¬SET-CAN/NUP214Èںϻ¼ÕßµÄÔ¤ºó¿ÉÒÔ´ó´ó¸ÄÉÆ£¬£¬£¬£¬£¬£¬£¬ÖÁÉÙ²»±ÈÆäËûT-ALL»¼Õ߲¡£¡£¡£¡£
ÏàÖúµ¥Î»ÏÈÈÝ
¿ÆÊÒ¼ò½é£ºÖйúÒ½¿Æ´óѧÁ¥ÊôµÚһҽԺѪҺÄڿƽ¨ÉèÓÚ1960Ä꣬£¬£¬£¬£¬£¬£¬ÊǶ«±±×ÅÃûµÄѪҺ²¡ÖÎÁÆÖÐÐÄ¡£¡£¡£¡£¡£¿£¿£¿ÆÊÒÓµÓÐͨËײ¡´²100ÕÅ£¬£¬£¬£¬£¬£¬£¬²ãÁ÷²¡´²4ÕÅ£¬£¬£¬£¬£¬£¬£¬ÑªÒº²¡ÊµÑéÊÒ1¸ö£¬£¬£¬£¬£¬£¬£¬ÄêÃÅÕïÊÕÖλ¼Õß35000ÓàÈ˴Σ¬£¬£¬£¬£¬£¬£¬Ä겡·¿ÊÕÖλ¼Õß½ü3000È˴Σ¬£¬£¬£¬£¬£¬£¬ÏÖÓÐÒ½Éú21Ãû¡£¡£¡£¡£¡£
ÊÖÒÕÖ§³Ö£ºÒ¼ºÅÓéÀÖ¹«Ë¾ÒÀÍÐÖйú¿ÆѧԺÁõÇàËÉÑо¿ÍŶӣ¬£¬£¬£¬£¬£¬£¬Ê¹ÓÃ×ÔÖ÷¿ª·¢µÄÔ´úϸ°û¿ÉÔÙÍâÐÐÒÕ¿ª·¢ÁËÁýÕÖÈ«°©ÖÖµÄHDSÒ©Ãô¼ì²âϵͳ£¨High-throuphput Drug Sensitivity Analysis Strategy£©£¬£¬£¬£¬£¬£¬£¬¿ÉÔÚ7-10ÌìÄÚʹÓÃÖ×Áö»¼ÕßÉÙÁ¿Ö×ÁöÑù±¾¾ÙÐÐÉÏ°ÙÖÖÒ©ÎïµÄÃô¸ÐÐÔ¼ì²â£¬£¬£¬£¬£¬£¬£¬×ÊÖúÖ×Áö»¼Õß½â¾ö“³Ôʲôҩ¡¢ÄÍÒ©¡¢ÎÞÒ©¿É³Ô”µÄÄÑÌ⣬£¬£¬£¬£¬£¬£¬¾ßÓÐÖÜÆڶ̡¢ÀÖ³ÉÂʸߡ¢¼ì²âÒ©Îï¶à¡¢ÁÙ´²Ò»ÖÂÐԸߵÈÌص㣬£¬£¬£¬£¬£¬£¬ÎªÖ×ÁöÒ½ÉúµÄ¸öÌ廯ÖÎÁƾöÒéÌṩ֤¾ÝÖ§³Ö¡£¡£¡£¡£¡£
С½á
Á½¸ö²¡Àý¶¼ÌáÐÑÔÚÓÐÊýÄÑÖÎÐÍ°×Ѫ²¡µÄÖÎÁÆÖУ¬£¬£¬£¬£¬£¬£¬¿É½ÓÄÉËèϵ¼Æ»®½â¾öÁÜϵÄÑÌâµÄ“ÀÏÒ©ÐÂÓÔÁ¢Òì˼Ð÷£¬£¬£¬£¬£¬£¬£¬¶øÌåÍâÒ©Ãô¿ÉÒÔÈÃÕâÑùµÄÑ¡ÔñÓоݿÉÒÀ£¬£¬£¬£¬£¬£¬£¬Á½Àýcase reportΪҩÃôɸ²éÖ¸µ¼ÏµĸöÌ廯׼ȷÖÎÁÆÌṩÁËÓÅÒìµÄ²Î¿¼Ä£Ê½¡£¡£¡£¡£¡£
Ò¼ºÅÓéÀÖ¹«ÖÚºÅ
Á¢ÒìÒ©ÎïÆÀ¼Û
ÖпÆÒ½ÂöС³ÌÐò
µç»°£º4006 0551 06£¨¹Ù·½ÈÈÏߣ©
0551—67129201£¨¹«Ë¾×ܲ¿£©
꿅᣼www.precedo.cn
µØµã£ººÏ·ÊÊиßÐÂÇøÏ°ÓÑ·¹ú¼Ò¿µ½¡´óÊý¾Ý¹¤ÒµÔ°A6¶°
Copyright © 2021 Ò¼ºÅÓéÀÖ °æȨËùÓÐ | SEO±êÇ©
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ºÏ·Ê